Skip to main content
Log in

Dopamine transporter density in patients with tardive dyskinesia: a single photon emission computed tomography study

  • Rapid Communication
  • Published:
Psychopharmacology Aims and scope Submit manuscript

Abstract.

Rationale: Tardive dyskinesia occurs frequently in schizophrenic patients chronically treated with classical antipsychotic medication. It may be caused by loss of dopaminergic cells, due to free radicals as a product of high synaptic dopamine levels. Objective: To evaluate dopamine transporter density in the striatum in patients with tardive dyskinesia. Methods: Striatal [123I]FP-CIT binding was measured with SPECT in seven schizophrenic patients with tardive dyskinesia and eight healthy controls. Results: No significant difference was found between striatal [123I]FP-CIT binding ratios in patients with tardive dyskinesia and controls. Conclusions: This preliminary study indicates no change in striatal dopamine transporter density in schizophrenic patients with tardive dyskinesia. This finding does not support the hypothesis that tardive dyskinesia is caused by dopaminergic cell loss.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Author information

Authors and Affiliations

Authors

Additional information

Electronic Publication

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lavalaye, J., Sarlet, A., Booij, J. et al. Dopamine transporter density in patients with tardive dyskinesia: a single photon emission computed tomography study. Psychopharmacology 155, 107–109 (2001). https://doi.org/10.1007/s002130000670

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s002130000670

Navigation